Jinlin Jiang, Ph.D.

Jinlin Jiang is a Director in Cell Therapy Technical Operation at AstraZeneca, where he leads cell line development, lentiviral vector engineering, and process development supporting AstraZeneca’s in vivo and ex vivo cell therapy programs. With more than a decade of experience in bioprocess development, Jinlin has built and advanced platforms spanning lentiviral vectors, adenovirus, autologous CAR-T, and oncolytic viruses, with expertise in process optimization, scale-up, characterization, technology transfer, and GMP manufacturing. His work encompasses global regulatory filings, clinical supply across internal and external manufacturing networks, and the development of innovative manufacturing solutions for cell and gene therapies.